Modifications in the respiratory physiotherapy treatment of patients with cystic fibrosis arising from the Covid-19 pandemic in the state of Piauí
DOI:
https://doi.org/10.33448/rsd-v11i14.36207Keywords:
Cystic Fibrosis; Physiotherapy; Covid-19.Abstract
Objectives: To identify the changes made, as a result of the Covid-19 pandemic, and their consequences in the respiratory physiotherapeutic treatment of patients with Cystic Fibrosis in the state of Piauí. Methodology: This is a cross-sectional, descriptive and quantitative research. The sample included all patients with a confirmed diagnosis of cystic fibrosis undergoing respiratory physiotherapeutic treatment in the state of Piauí, who were contacted and accepted to be part of the research. The collected data were tabulated and analyzed in Excel. Results: 70% of the sample said they felt unmotivated about the physical therapy treatment due to isolation. Home treatment was another challenge, as they found it difficult to perform breathing exercises and conducts. None of them had online physical therapy follow-up. The presence of some exacerbations of the respiratory clinical picture during the pandemic was also identified. Conclusions: It is concluded that the Covid-19 pandemic had a negative impact on the respiratory physiotherapeutic treatment routine of the individuals in the sample, leading to relevant changes in mandatory treatment, home care and quality of life.
References
Alexandra, L. Q. (2020). 20 Facts about Cystic Fibrosis. Adherence Self-Management Pediatr Popul, 196:107–32. www.informahealthcare.com.
Athanazio, R. A., Vicente, L., Ferreira, R., Vergara, A. A., Ribeiro, A. F., Riedi, C. A., Procianoy, E. F. A., Adde, F. V., Reis, F. J. C., Ribeiro, J. D., Torres, L. A., Fuccio, M. B., Epifanio, M., Firmida, M. C., Damasceno, N., Ludwig-Neto, N., Maróstica, P. J. C., & Rached, S. Z. (2017). Diretrizes brasileiras de diagnóstico e tratamento da fibrose cística. J Bras Pneumol, 43(3), 219–45.
Baloch, S., Baloch, M. A., Zheng, T., & Pei, X. (2020). The coronavirus disease 2019 (COVID-19) pandemic. Tohoku J Exp Med, 250(4), 271–8.
Brown, S. D., White, R., & Tobin, P. (2017). Keep them breathing: Cystic fibrosis pathophysiology, diagnosis, and treatment. J Am Acad Physician Assist, 30(5), 23–7.
Button, B. M., Wilson, C., Dentice, R., Cox, N. S., Middleton, A., Tannenbaum, E., Bishop, J., Coob, R., Burton, K., Wood, M., Moran, F., Black, R., Bawen, S., Day, R., Depiazzi, J., Doiron, K., Doumit, M., Dwyer, T., Elliot, A., Fuller, L., Hall, K., Hutchins, M., Keer, M., Lee, A. L., Mans, C., O`Connor, L., Steward, R., Potter, A., Rosekaba, T., Scoones, R., Tarrant, B., Ward, N., West, S., White, D., Wilson, L., Wood, J., & Holland. A. E. (2016). Physiotherapy for cystic fibrosis in Australia and New Zealand: A clinical practice guideline. Respirology, 21(4), 656–67.
Collaço, N., Legg, J., Day, M., Culliford, D., Campion, A., West, C., & Darlington, A. S. (2021). COVID-19: Impact, experiences, and support needs of children and young adults with cystic fibrosis and parents. Pediatr Pulmonol, 56(9), 2845–53.
Colombo, C., Burgel, P. R., Gartner, S., van Koningsbruggen-Rietschel, S., Naehrlich, L., Sermet-Gaudelus, I., & Southern, K. W. (2020). Impact of COVID-19 on people with cystic fibrosis. Lancet Respir Med, 8(5), e35–6.
Conitec. Conitec em tempo real – 93a Reunião da Conitec. (2021). http://conitec.gov.br/conitec-em-tempo-real-93-reuniao-da-conitec.
Conway, S., Balfour-Lynn, I. M., De Rijcke, K., Drevinek, P., Foweraker, J., Havermans, T., Heijerman, H., Lannefors, L., Lindblad, A., Macek, M., Madge, S., Moran, M., Morrison, L., Morton, A., Noordhoek, J., Sands, D., Vertommen, A., & Peckham, D. (2014). European cystic fibrosis society standards of care: Framework for the cystic fibrosis centre. J Cyst Fibros, 13(S1), S3–22.
De Boeck, K. (2020). Cystic fibrosis in the year 2020: A disease with a new face. Acta Paediatr Int J Paediatr, 109(5), 893–9.
Dowd, C., Van Citters, A. D., Dieni, O., Willis, A., Powell, L., & Sabadosa, K. A. (2021). Design and methods for understanding the state of cystic fibrosis care amid the COVID-19 pandemic. J Cyst Fibros, 20, 3–8.
GBEFC. Relatório do Registro Brasileiro de Fibrose Cística 2018 – REBRAFC. http://portalgbefc.org.br/site/pagina.php?idpai=128&id=15.
Instituto Unidos pela Vida. Kalydeco teve recomendação favorável da conitec: e agora? https://unidospelavida.org.br/kalydecorecomendacaofavoraveleagora/.
Khan, M., Syed, F. A., Hamad, Z. A., Muhammad, N. T., Saif, S., Khan, M., & Khan, S. T. (2021). Epidemiology and Progress So Far. Moléculas, 26(1), 1–25.
Lopes-Pacheco, M. (2020). CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine. Front Pharmacol, 10, 1–29.
Loukou, I., Moustaki, M., Petrocheilou, A., Zarkada, I., & Douros, K. (2021). Impact of COVID-19 Lockdown on Pulmonary and Nutritional Status in Children and Young Adults With Cystic Fibrosis, in Greece. J Patient Exp, 8, 1–3.
Mason, K., Hasan, S., Darukhanavala, A., & Kutney, K. (2021). COVID-19: Pathophysiology and implications for cystic fibrosis, diabetes and cystic fibrosis-related diabetes. J Clin Transl Endocrinol, 26, 100268.
Mondejar-Lopez, P., Quintana-Gallego, E., Giron-Moreno, R. M., Cortell-Aznar, I., Ruiz de Valbuena-Maiz, M., Diab-Caceres, L., Prados-Sanchez, C., Alvarez-Fernandez, A., Garcia-Marcos, P. W., Peñalver-Mellado, C., Pastor-Vivero, M. D., Olveira, C., Lopez-Neyra, A., Castillo-Corullon, S., Palma-Milla, S., Perez-Ruiz, E., Sole-Jover, A., Barrio, M. I., Sanchez-Solis, M., Asensio de la Cruz Ó; & CF-COVID19-Spain Registry Group. (2020). Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey. Respir Med, 170.
Oliveira, E., & Souza, A. (2017). A importância da realização precoce do teste do pezinho: O papel do enfermeiro na orientação da triagem neonatal. Rev. Psic, 11(35), 361-378.
Patel, S., Thompson, M. D., Slaven, J. E., Sanders, D. B., & Ren, C. L. (2021). Reduction of pulmonary exacerbations in young children with cystic fibrosis during the COVID-19 pandemic. Pediatr Pulmonol, 56(5), 1271–3.
Pereira A. S. et al. (2018). Metodologia da pesquisa científica. [free e-book]. Santa Maria/RS. Ed. UAB/NTE/UFSM.
Pollard, C. A., Morran, M. P., & Nestor-kalinoski, A. L. (2022). The COVID-19 pandemic: a global health crisis. Physiological Genomics, 549–57.
Radtke, T., Haile, S. R., Dressel, H., & Benden, C. (2020). Recommended shielding against COVID-19 impacts physical activity levels in adults with cystic fibrosis. J Cyst Fibros, 19(6), 875–9.
Rafeeq, M. M., & Murad, H. A. S. (2017). Cystic fibrosis: Current therapeutic targets and future approaches. Journal of Translational Medicine, 15.
Rhoads, S., Cooney, K., & Banerjee, D. (2021). Emotional Impact of COVID-19 Pandemic on Adults with Cystic Fibrosis. R I Med J, 104(10), 53–5.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Mariana Antonia de Carvalho Ferreira; Anne Shirley Menezes Costa; Telmo Macedo de Andrade; Maíra Damasceno Cunha Varanda
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
